HSB 766

As introduced: - Establishes the Board of Autonomous Medical Practice to license and regulate artificial intelligence augmented and autonomous service providers (AAASPs). - Creates a mandatory licensing framework for entities operating certain clinical AI services, with license classes based on function and U.S. Food and Drug Administration clearance status. - Authorizes certain licensed AAASPs to issue clinical orders and prescriptions for non-controlled substances. - Waives the corporate practice of medicine doctrine for licensed AAASPs and limits liability for noneconomic damages for providers operating under a provisional license. - Requires state Medicaid and private health carriers to establish reimbursement mechanisms and cover medically necessary services provided by licensed AAASPs.